SecProbe.io

CORRESP
1
filename1.htm

BioLingus
(Cayman) Limited

January
26, 2024

VIA
EDGAR

Tyler
Howes/ Jason Drory

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Manufacturing

100
F Street, NE

Washington,
D.C., 20549

    Re:
    BioLingus
    (Cayman) Limited

    Registration
    Statement on Form F-1, as amended (File No. 333-273093)

    Request
    for Acceleration of Effectiveness

Ladies
and Gentlemen:

In
accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, BioLingus (Cayman) Limited
hereby requests acceleration of the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, so that such
Registration Statement will become effective at 5:00 p.m., Eastern Time, on January 31, 2024, or as soon thereafter as practicable.

The
Company understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement
as a confirmation of the fact that the Company is aware of its responsibilities under the Securities Act as they relate to the proposed
public offering of the securities specified in the Registration Statement.

    Very
    truly yours,

    BioLingus
    (Cayman) Limited

    By:
    /s/
    Yves Decadt

    Name:
    Yves
    Decadt

    Title:
    Chief
    Executive Officer